In summary: Cef can relieve TNP through suppression of spatiotemporal synaptic plasticity via GLT-1 restoration in the medullary dorsal horn of the trigeminal nerve and is promising as a novel therapeutic target for the treatment of TN, in particular, and other neuropathic pains, in general. Here, SLC1A2 is linked to neuropathic pain.